Press Release VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets 17 hours ago
Press Release Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis 17 hours ago
Press Release Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients Aug 12